Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vance G Fowler

Showing results (351-360 of 426) with videos related to

Pageof 43
Sort By:
Open Forum Infectious Diseases|October 14, 2017
A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant <i>Enterobacteriaceae</i>Oryan Henig, Eric Cober, Sandra S Richter, et al.
Plos One|February 6, 2014
Metabolomic derangements are associated with mortality in critically ill adult patientsAngela J Rogers, Michael McGeachie, Rebecca M Baron, et al.
Antimicrobial Agents and Chemotherapy|October 30, 2024
ARGONAUT-IV: susceptibility of carbapenemase-producing <i>Klebsiella pneumoniae</i> to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibutenMichael R Jacobs, Caryn E Good, Ayman M Abdelhamed, et al.
Antimicrobial Agents and Chemotherapy|August 12, 2024
ARGONAUT-III and -V: susceptibility of carbapenem-resistant <i>Klebsiella pneumoniae</i> and multidrug-resistant <i>Pseudomonas aeruginosa</i> to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepimeMichael R Jacobs, Ayman M Abdelhamed, Caryn E Good, et al.
Science Advances|July 1, 2026
Loss of O-antigen due to <i>wbbL</i> mutations is common and associated with increased mortality in <i>Escherichia coli</i> bloodstream infectionsKaleb J Tyson, Amanda Z Velez, Blake M Hanson, et al.
Open Forum Infectious Diseases|January 12, 2019
The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant <i>Enterobacteriaceae</i>Courtney L Luterbach, Ashley Boshe, Heather I Henderson, et al.
American Heart Journal|November 24, 2007
The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS)Stuart A Dickerman, Elias Abrutyn, Bruno Barsic, et al.
JAMA|April 4, 2013
Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trialVance G Fowler, Keith B Allen, Edson D Moreira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on MortalityLaura J Rojas, Madiha Salim, Eric Cober, et al.
JAMA|April 27, 2012
Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devicesEugene Athan, Vivian H Chu, Pierre Tattevin, et al.
Pageof 43

Showing results (351-360 of 426) with videos related to

Sort By:
Pageof 43
Open Forum Infectious Diseases|October 14, 2017
A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant <i>Enterobacteriaceae</i>Oryan Henig, Eric Cober, Sandra S Richter, et al.
Plos One|February 6, 2014
Metabolomic derangements are associated with mortality in critically ill adult patientsAngela J Rogers, Michael McGeachie, Rebecca M Baron, et al.
Antimicrobial Agents and Chemotherapy|October 30, 2024
ARGONAUT-IV: susceptibility of carbapenemase-producing <i>Klebsiella pneumoniae</i> to the oral bicyclic boronate β-lactamase inhibitor ledaborbactam combined with ceftibutenMichael R Jacobs, Caryn E Good, Ayman M Abdelhamed, et al.
Antimicrobial Agents and Chemotherapy|August 12, 2024
ARGONAUT-III and -V: susceptibility of carbapenem-resistant <i>Klebsiella pneumoniae</i> and multidrug-resistant <i>Pseudomonas aeruginosa</i> to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepimeMichael R Jacobs, Ayman M Abdelhamed, Caryn E Good, et al.
Science Advances|July 1, 2026
Loss of O-antigen due to <i>wbbL</i> mutations is common and associated with increased mortality in <i>Escherichia coli</i> bloodstream infectionsKaleb J Tyson, Amanda Z Velez, Blake M Hanson, et al.
Open Forum Infectious Diseases|January 12, 2019
The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant <i>Enterobacteriaceae</i>Courtney L Luterbach, Ashley Boshe, Heather I Henderson, et al.
American Heart Journal|November 24, 2007
The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS)Stuart A Dickerman, Elias Abrutyn, Bruno Barsic, et al.
JAMA|April 4, 2013
Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trialVance G Fowler, Keith B Allen, Edson D Moreira, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on MortalityLaura J Rojas, Madiha Salim, Eric Cober, et al.
JAMA|April 27, 2012
Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devicesEugene Athan, Vivian H Chu, Pierre Tattevin, et al.
Pageof 43